US Patent 7288527 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
Patent 7288527 was granted and assigned to Oklahoma Medical Research Foundation on October, 2007 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7288527 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
